|
H. Lundbeck A/S - Sales Analysis Snapshot
Business Description This Report provides a comprehensive Sales & Margin summary analysis for H. Lundbeck A/S Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.
H. Lundbeck A/S. The Group's principal activities are the research, development, production, marketing and sale of pharmaceuticals for treating diseases of the central nervous system (CNS). The Group specialises in psychiatry and neurology, focusing exclusively on treatments of psychosis, depression, anxiety, schizophrenia, Parkinson's disease, Alzheimer's disease and dementia. The product group includes Cipralex, Lexapro, Azilect and other pharmaceuticals. The Group operates globally in 54 countries.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|